Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis.
about
Statin use and breast cancer survival and risk: a systematic review and meta-analysisStatins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studiesPrevious Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control StudyAssociations between statin use and non-Hodgkin lymphoma (NHL) risk and survival: a meta-analysis.Statin use and risk of multiple myeloma: An analysis from the cancer research network.
P2860
Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Statin use is associated with ...... evidence from a meta-analysis.
@en
Statin use is associated with ...... evidence from a meta-analysis.
@nl
type
label
Statin use is associated with ...... evidence from a meta-analysis.
@en
Statin use is associated with ...... evidence from a meta-analysis.
@nl
prefLabel
Statin use is associated with ...... evidence from a meta-analysis.
@en
Statin use is associated with ...... evidence from a meta-analysis.
@nl
P2093
P2860
P1433
P1476
Statin use is associated with ...... evidence from a meta-analysis.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0087019
P407
P577
2014-01-31T00:00:00Z